Zobrazeno 1 - 10
of 127
pro vyhledávání: ''
Publikováno v:
Anticancer Research. 41:5001-5006
Background/aim To describe clinical features, radiotherapy (RT), and symptom outcomes in cancer patients with cranial nerve palsies associated with clival metastases. Patients and methods This is a retrospective review of patients with primary metast
Autor:
Hideo Baba, Taishi Yamane, Shinya Shimada, Kei Horino, Daisuke Izumi, Chika Shirakami, Keisuke Morita, Satoshi Ikeshima, Shotaro Kinoshita
Publikováno v:
Anticancer Research. 41:5223-5229
AIM The aim of the current study was to investigate whether the artery-first approach (AFA) improved surgical outcomes of pancreaticoduodenectomy (PD) at our non-high-volume center. PATIENTS AND METHODS We retrospectively reviewed data on 121 consecu
Publikováno v:
Anticancer Research. 41:4529-4534
BACKGROUND/AIM Blood transfusion and a large amount of intraoperative blood loss (IBL) have been reported to have a negative impact on long-term survival via immunosuppression. In recent years, thanks to the spread of laparoscopic surgery and the dev
Autor:
Junichi Ikeda, Takashi Yoshida, Chisato Ohe, Hidefumi Kinoshita, Koji Tsuta, Haruyuki Ohsugi, Motohiko Sugi
Publikováno v:
Anticancer Research. 41:4577-4586
Background/aim Expression of programmed death ligand-1 (PD-L1) is associated with poor prognosis in renal cell carcinoma (RCC). Although a new antibody clone for immunohistochemical assay, 73-10, has shown greater sensitivity than other assays (28-8,
Autor:
Tetsuya Ikemoto, Shinichiro Yamada, Yu Saito, Mitsuo Shimada, Yuji Morine, Kazunori Tokuda, Masaaki Nishi, Katsuki Miyazaki
Publikováno v:
Anticancer Research. 41:4637-4644
Background/aim The aim of this study was to investigate frailty as a prognostic factor in patients with colorectal liver metastasis undergoing hepatectomy. Patients and methods Eighty-seven patients who underwent hepatectomy at our institution were e
Autor:
Ioannis Anestopoulos, Achilleas Mitrakas, Mihalis I. Panayiotidis, Alexandra Giatromanolaki, Aglaia Pappa, Michael I. Koukourakis
Publikováno v:
Anticancer Research. 41:3989-3995
Background/aim Non-small cell lung cancer (NSCLC) is one of the most lethal tumors. Given the failure of conventional therapeutic strategies, immunotherapy has emerged as a promising treatment modality that may improve the survival of patients with o
Publikováno v:
Anticancer Research. 41:4133-4141
Background/aim Advanced/recurrent breast cancer (ARBC) still has a poor prognosis; therefore, new treatment strategies are required. In this retrospective study, we aimed to investigate the efficacy of immune-cell therapy using T lymphocytes activate
Autor:
Atsushi Kagimoto, Akihisa Saito, Kazuya Kuraoka, Kikuo Nakano, Yoshinori Yamashita, Kiyomi Taniyama, Akira Ishikawa, Tadashi Senoo, Tetsu Hirakawa, Takeshi Mimura, Kazuhide Fukuhara, Junichi Zaitsu, Mineyo Mito
Publikováno v:
Anticancer Research. 41:3673-3682
AIM This study aimed to investigate useful prognostic factors of immunotherapy in patients with lung cancer. PATIENTS AND METHODS We retrospectively observed 73 patients who underwent immunotherapy (nivolumab, pembrolizumab, and atezolizumab) for lun
Publikováno v:
Anticancer Research. 41:2563-2568
Background/aim The aim of this study was to evaluate the effect of drug-induced interstitial lung disease (DILD) on treatment outcomes by comparing the mortality of patients with DILD induced by different pharmacological types of anticancer drugs. Pa
Autor:
Josef Vodicka, Gabriela Krakorova, Jiri Blazek, Zuzana Teufelova, Magda Barinova, Karolina Hurdalkova, Marcela Buresova, Martin Svaton, Ondrej Topolcan, Miloš Pešek
Publikováno v:
Anticancer Research. 41:2053-2058
Aim To investigate potential associations between selected oncomarkers [carcinoembryonic antigen (CEA), C-terminus of cytokeratin 19 (CYFRA 21-1, CYFRA), and squamous cell carcinoma antigen (SCC)] and outcomes in patients with NSCLC treated with beva